Found 65 All Conditions trials

Below is a list of actively recruiting clinical trials based on your search for "All Conditions"

18 years - 75 years
All genders
Phase 2
Interventional
This study investigates the effects of different doses of an investigational medication compared to a placebo for Crohn's disease.The purpose of this study is to understand the safety and effectiveness of the investigational medication for people with Crohn's disease.Who can participate: Adults with moderate to severe Crohn's disease, who have …
18 years or above
All genders
Phase 3
Interventional
This study investigates immune thrombocytopenia (ITP) in adults who did not respond to first-line treatment. The purpose of this study is to explore the effects of the investigational medication on this condition.The study evaluates the safety and effectiveness of the investigational medication. It looks at how well the medication works …
1 year - 18 years
All genders
Phase 2
Interventional
This study investigates chronic graft versus host disease (cGVHD) in children. The purpose of this study is to evaluate an investigational medication in children who have this condition.The study will assess the safety and effectiveness of the investigational medication in treating cGVHD. Researchers will evaluate how well the medication works …
16 years - 80 years
All genders
Phase 3
Interventional
This study investigates how participants with moderately to severely active Crohn's Disease respond to an investigational medication.The purpose of this study is to assess the safety and effectiveness of the investigational medication. It focuses on understanding its impact on those with moderately to severely active Crohn's Disease.Who can participate: Participants …
16 years - 80 years
All genders
Phase 3
Interventional
This study investigates moderately to severely active Crohn's Disease. The purpose of this study is to explore how the investigational medication affects individuals with this condition.The study evaluates the safety and effectiveness of the investigational medication over a prolonged period. It seeks to understand how participants respond to the treatment.Who …
18 years or above
All genders
Phase 1
Interventional
This study investigates advanced solid tumors.The study evaluates the safety of an investigational medication in treating advanced solid tumors that are difficult to manage.Who can participate: Adults with advanced solid tumors that have not improved with standard treatments may participate. Participants must have a type of cancer that cannot be …
18 years - 60 years
All genders
Phase 3
Interventional
This study investigates different administration methods for frexalimab, an investigational medication, to determine if one method is as effective as the other.The study evaluates the safety and effectiveness of administering frexalimab through a shot under the skin compared to an IV. It checks if both methods are equally beneficial for …
42 days - 89 days
Accepts healthy volunteer
All genders
Phase 3
The purpose of this study is to investigate a 21-valent pneumococcal conjugate vaccine in healthy infants. The study examines how infants' bodies respond to different lots of this investigational vaccine.This study evaluates the immune response and safety of the investigational vaccine compared to a licensed vaccine. It focuses on understanding …
18 years - 70 years
All genders
Phase 2/3
Interventional
This study investigates kidney transplantation. It evaluates the condition in adults receiving their first kidney transplant.The study evaluates the effectiveness and safety of an investigational medication compared to another medication. It checks how well the treatments work and how safe they are for participants.Who can participate: Adults aged 18 to …
12 years or above
Male
Phase 4
Interventional
This study investigates severe hemophilia. The purpose is to explore the effects of switching treatment from emicizumab to an investigational medication.The study evaluates the safety and tolerability of the investigational medication in participants who have previously been on emicizumab.Who can participate: The study is for male participants aged 12 years …